Pfizer, Gates Foundation team up on low-cost injectable contraceptive

Pfizer ($PFE) inked a deal with the Bill & Melinda Gates Foundation to roll out a long-acting contraceptive in 69 of the world's poorest countries. The drug is a version of its injectable Depo-Provera, packaged in capsule syringes for easy transport and injection. The product will be sold for about $1 per dose, subsidized by the foundation and the U.S. government. Report (sub. req.)

Suggested Articles

After early threats, the FDA finished reviewing the company's response to a citation for data manipulation and decided not to take any further action.

China is quickly getting back up to speed with API production but reports freight bottlenecks are slowing deliveries.

Mylan and Pfizer have already postponed the close of their generic merger amid COVID-19 concerns. Now the pair is hoping to speed up EU review.